Beneficial Effect of Oral Bisphosphonate Treatment on Bone Loss Induced by Chronic Administration of Furosemide without Alteration of Its Administration and Urinary Calcium Loss

Bisphosphonate is widely used to treat patients with primary and secondary osteoporosis. The chronic administration of furosemide is considered a risk factor for osteoporosis mainly due to the increased urinary excretion of calcium, leading to a long-term negative balance of calcium. We describe two...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Takuo, Namba, Noriyuki, Kurotobi, Shunji, Kogaki, Shigetoyo, Hirai, Haruhiko, Kitaoka, Taichi, Nakajima, Shigeo, Ozono, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Pediatric Endocrinology 2006
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004841/
https://www.ncbi.nlm.nih.gov/pubmed/24790329
http://dx.doi.org/10.1297/cpe.15.101

Ejemplares similares

Ejemplares similares